Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Caplyta® (lumateperone) – New dosage strengths
April 25, 2022 - Intra-Cellular Therapies announced the FDA approval of new dosage strengths of Caplyta (lumateperone), 10.5 mg and 21 mg capsules, for specific patient populations.
